A 595 nm pulsed dye laser as an adjuvant intervention for post‐comedone extraction erythema and comedone reduction: A randomized, split‐face controlled trial
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16178 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Rungrot Bencharattanaphakhi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Dermatology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital,…. Hauptthemen laut MEDLINE: Lasers, Dye, Erythema, Patient Satisfaction, Acne Vulgaris. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Chulalongkorn University, Ratchadapiseksompoch Fund.
Abstract (Originalsprache)
Background
Comedone extraction provides greater satisfaction for acne treatment than conventional treatment alone; however, post‐comedone extraction erythema (PCEE) remains a concern for patients.
Objectives
To evaluate the efficacy of pulsed‐dye laser (PDL) in PCEE and comedone reduction.
Methods
Mild‐to‐moderate acne patients were randomly allocated in split‐face fashion. Three comedones were extracted on each facial side. On the PDL‐treated side, 595‐nm PDL was delivered to the entire side with an additional shot on three comedone‐extracted sites. Erythema index (EI) and total acne lesion counts (TALC) were evaluated at baseline, week 2 and 4. The comprehensive acne severity scale (CASS) was assessed by three blinded independent pediatric dermatologists. Participant satisfaction surveys were completed at the end of the study.
Results
Thirty‐five participants (age 12.9–24.2 years) showed no differences in the EI and TALC at baseline on both sides. At weeks 2 and 4, the EI on the PDL‐treated side was significantly lower ( p < 0.001) with a greater EI reduction ( p < 0.001) when compared to the control side regardless of gender and menstruation. There was significantly lower TALC on the PDL‐treated side at week 2 ( p < 0.001) and week 4 ( p = 0.02). No complications were noted with high participant satisfaction reported (median 8; IQR 7–9). PDL remained significantly associated with EI improvements after controlling for gender, menstruation cycle, and examination stress.
Conclusion
PDL can be an adjunctive intervention for the treatment of PCEE and comedone reduction due to its effectiveness and high participant satisfaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Dermatology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- Division of Pediatric Dermatology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
ORCID-Profile: Susheera Chatproedprai
Förderung
- Faculty of Medicine, Chulalongkorn University
- Ratchadapiseksompoch Fund
Zitieren
APA
Bencharattanaphakhi, R., Wananukul, S., Tempark, T., & Chatproedprai, S. (2024). A 595 nm pulsed dye laser as an adjuvant intervention for post‐comedone extraction erythema and comedone reduction: A randomized, split‐face controlled trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16178
Vancouver
Bencharattanaphakhi R, Wananukul S, Tempark T, Chatproedprai S. A 595 nm pulsed dye laser as an adjuvant intervention for post‐comedone extraction erythema and comedone reduction: A randomized, split‐face controlled trial. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16178
BibTeX
@article{Bencharattanaphakhi2024,
author = {Bencharattanaphakhi, Rungrot and Wananukul, Siriwan and Tempark, Therdpong and Chatproedprai, Susheera},
title = {A 595 nm pulsed dye laser as an adjuvant intervention for post‐comedone extraction erythema and comedone reduction: A randomized, split‐face controlled trial},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16178}
}
EUVIMED